In the United States, almost half of women diagnosed with cervical cancer are under
the age of 35 year [6]. In younger women diagnosed with cervical carcinoma. The desire to maintain fertility without compromising long-term survival is an important issue. As more knowledge is gained regarding the pathogenesis of cervical cancer, conservative treatment of earlystage cervical carcinoma has been proposed as a reasonable option. Studies of conservative treatment for patients diagnosed with adenocarcinoma in situ of the cervix have suggested that cone biopsy alone may be appropriate for patients in whom a negative margin is obtained in the cone biopsy [7, 8]. Other